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Copyright © 2008 JCBN Summary We evaluated the effect of cacao procyanidins (CP) on plasma lipid levels in high
cholesterol-fed rats. Animals were divided into 4 groups, and each group was fed on either a
normal diet, high cholesterol diet (HCD) containing 1% cholesterol (HCD without CP), HCD
with 0.5% (HCD with 0.5% CP) or 1.0% CP (HCD with 1.0% CP) for 4 weeks. Plasma
cholesterol level was significantly higher in the HCD without CP group than the normal diet
group (p<0.01). Supplementation of CP significantly decreased plasma cholesterol (p<0.01) to
levels similar to those of the normal diet group. The liver cholesterol and triglyceride levels in
all HCD groups were significantly higher (p<0.01), but 1.0% CP feeding significantly reduced
this increase. Fecal excretion of neutral sterol and triglyceride was significantly increased in
all HCD groups (p<0.01), and the excreted amounts tended to be higher in the HCD with CP
groups. The procyanidins dose-dependently reduced micellar solubility of cholesterol and this
activity increased with increasing molecular weight. These results suggest that one of the
mechanisms of CP to lower plasma cholesterol is inhibition of intestinal absorption of cholesterol.
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Introduction
Cacao bean, the seed of Theobroma cacao, is known to be
rich in polyphenols, such as the procyanidin monomers ((+)-
catechin and (−)-epicatechin) and oligomers (B-type
procyanidins that are linked by C4–C8 bonds) [1–3]. Recent
epidemiological evidence suggests that the ingestion of
monomers of procyanidins prevents coronary heart diseases
[4, 5]. In addition, several reports have indicated that the
susceptibility of low-density lipoprotein (LDL) to oxidation
was significantly decreased in humans [6–8] and high
cholesterolemic rabbits [9] by dietary supplementation with
cocoa or its procyanidins fraction. Moreover, many reports
support the possibility that procyanidins in cacao can
prevent cardiovascular disease by improving blood flow
rate [10], improving platelet function [11,  12], changing
inflammatory responses in endothelial cells of blood vessels
[13, 14], and so on. On the other hand, many reports attribute
the decrease in plasma cholesterol levels in experimental
animals to the ingestion of tea [15], citrus fruit [16], grape
[17] and wine flavanoids [18].
In this report, we evaluated the plasma cholesterol
lowering activity of cacao procyanidins (CP) in rats fed a
high cholesterol diet.
Materials and Methods
Ethics
The protocol of this study was approved by the Animal
Care and Use Committee of Meiji Seika Food and Health
Laboratories. All animals received humane care under theN. Osakabe et al.
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guidelines of this institution.
Animals and diets
Nine-week-old male Sprague-Dawley rats were obtained
from Crea Japan Inc. (Tokyo, Japan). The rats were housed
individually and kept in a room at regulated temperature 23–
25°C and controlled lighting (12-h light and dark cycle). CP
was prepared from cacao liquor by the method described in
a previous report [19]. Briefly, cacao liquor was defatted
with  n-hexane, and then the residue was extracted with
acetone. The n-butanol soluble fraction of the extract was
applied to a Diaion HP2MG column (Mitsubishi Kasei Co.
Ltd., Tokyo, Japan). The fraction eluted with 80% ethanol
was collected, freeze dried, and then used. The composition
of the CP is as follows: total polyphenols, 79.3%; (+)-
catechin, 2.5%; (−)-epicatechin, 5.9%; procyanidins B2,
4.0%; procyanidins C1, 2.6%; and cinnamtannin A2, 3.2%.
Experimental procedure
The animals were fed on a basal diet (MF, Oriental Yeast,
Co. Ltd., Tokyo, Japan) for 4 days. Forty rats were divided
into four groups, and each group was fed on experimental
diets for 4 weeks: either a normal diet (AIN-93 diet), high
cholesterol diet (HCD) (containing 1% cholesterol and 15%
fat), HCD with 0.5% CP, or HCD with 1.0% CP. The dose of
CP (0.5% and 1.0%) was selected for testing because 1.0%
CP-containing diet showed significant reduction of athero-
sclerotic lesion formation in previous animal model studies.
Blood was taken from the tail vein before and at the end of
each week during the feeding period, and the plasma
cholesterol level was measured. To determine the excretion
of neutral sterol and triglyceride, feces were collected at 2
and 4 weeks of the experiment. At the end of the experiment,
each animal was anesthetized with ethyl ether, a blood
sample was taken from the abdominal vein, and the liver was
removed and stored at −80°C until analysis.
Analysis
Cholesterol in plasma was measured enzymatically using
the Cholesterol C-test Wako (Wako Pure Chemical Industries,
Tokyo, Japan). Other plasma components were also measured
using commercially available kits (Wako Pure Chemical
Industries). Liver and feces lipids were extracted with
methanol and chloroform according to the method described
in Folch et al. [ 20]. Triglyceride in liver and feces and
cholesterol in liver were measured using commercially
available kits as mentioned above. Neutral sterol in feces
was determined by the method of Sautier et al. with a kit
(Wako Pure Chemical Industries).
In vitro study
The effect of CP on micellar solubility was measured by
the method of Ikeda et al. with slight modification [21].
Briefly, a micellar solution containing 6.6 mM sodium
taurocholate, 0.6 mM egg yolk phosphatidylcholine, 0.5 mM
cholesterol, 132 mM NaCl, and 15 mM sodium phosphate at
pH 7.4 was prepared by sonication and kept at 37°C. Exactly
100 μl of various concentrations of CP, or solutions of
monomeric, dimeric, trimeric, or tetrameric procyanidins
was added to 5 ml of micellar solution, and the mixtures
were incubated for 1 h at 37°C and centrifuged at 1000 × g
for 10 min. The cholesterol concentration of the supernatant,
which was still soluble in the micellular mixture, was
measured using a commercially available kit. Procyanidin
monomer and oligomer fractions were prepared using a
previously reported method [22]. Briefly, CP was injected
onto a semipreparative HPLC column (Supelcosil LC-Si),
eluted with a dichloromethane – methanol – formic acid –
water linear gradient, and collected.
Statistical analysis
The data are expressed as the mean and standard devia-
tion. Analyses were performed using the SPSS statistical
software package (SPSS Inc., Chicago, IL). Comparisons of
the multi-groups in the in vivo and in vitro studies were made
using ANOVA followed by Tukey’s multiple comparison
test.
Results
Animal study
Body weight and food intake were significantly higher in
all HCD groups than in the normal diet group, and were not
influenced by CP treatment (Table 1). The total cholesterol
concentration in plasma was markedly increased throughout
the experimental period by ingestion of the HCD (Fig. 1). In
contrast, this increase was strikingly inhibited by CP supple-
mentation. The plasma total cholesterol levels were similar
in the CP groups and the normal diet group. Table 2 shows
free cholesterol, cholesterol ester, triglyceride, phospho-
lipids, and free fatty acid levels at the end of the experiment.
A significant difference between the normal diet group and
the HCD without CP group was seen in free cholesterol but
not in the other plasma lipid levels.
Liver weight, and cholesterol and triglyceride levels in
liver are shown in Table 3. Liver weight was significantly
different between the normal diet group and all HCD groups
and was not affected by CP. Cholesterol and triglyceride
levels in liver were markedly increased by the HCD and
significantly lower in the rats fed on the HCD with 1% CP
than in those fed on the HCD without CP.
Fecal excretion levels of neutral sterol and triglyceride
were markedly increased by ingestion of the HCD (Fig. 2).
After 2 weeks of feeding, neutral sterol excretion was
significantly higher in rats fed on the HCD with 1% CP than
rats fed on the HCD without CP. At 4 weeks, this differenceCacao Procyanidins Reduce Rat Plasma Cholesterol
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persisted but was not significant. Similarly, increase in
triglyceride excretion in both CP groups was significant at
2 weeks but not significant at 4 weeks.
In vitro study
The effect of catechins on micellar solubility of cholesterol
in vitro is shown in Fig. 3. The addition of CP to a mixed
micellar solution caused precipitation of cholesterol and
decreased cholesterol concentration in the supernatant. Each
of the procyanidins increased the precipitation rate in a dose-
dependent manner. The effect of procyanidins on precipita-
tion of micellar cholesterol increased with the size of the
oligomer as follows: tetramer > trimer > CP (procyanidins
mixture) > dimer > monomer.
Discussion
In this study, ingestion of CP reduced plasma total
cholesterol levels in rats fed on a high cholesterol diet
(Fig. 1). The accumulation of cholesterol and triglyceride in
liver of HCD-fed rats was significantly decreased by addi-
tion of 1% CP to the diet (Table 2). In addition, fecal excre-
tion of neutral sterol and triglyceride in the 1% CP group on
the HCD was significantly increased at 2 weeks but not
significantly increased at 4 weeks (Fig. 2). This difference
between 2 and 4 weeks might indicate a certain type of
adaptation. According to these data, CP might inhibit
intestinal absorption of dietary cholesterol and triglyceride.
Then we examined the effect of CP and its components on
cholesterol micellar solubility. All procyanidins used in this
study (from monomers to tetramers) precipitated micellar
cholesterol and this ability was dependent on their molecular
weight. Ikeda et al. reported that tea catechins inhibited
the intestinal absorption of cholesterol [21]. Of the tea
catechins, free catechins such as (−)-epicatechin and (−)-
epigallocatechin  showed  slight  activity,  while  their
gallate esters such as (−)-epicatechin gallate and (−)-
epigallocatechin gallate were more effective. Effectiveness
was correlated with ability to precipitate cholesterol in mixed
bile salt micelles. Ikeda et al. suggested that the catechins
were co-precipitated with cholesterol, and modified
cholesterol was converted to insoluble forms that could not
be absorbed from the intestine. In this report, we confirmed
that procyanidin monomers (like free catechins [(+)-catechin
and (−)-epicatechin]) have low activity, as previously
reported. The present data show that the ability of procyani-
dins to precipitate cholesterol correlated with degree of
Table 1. Body Weight and Food Intake and Food Efficiency of
Rats Fed the Experimental Diet
Values were mean and standard deviation.
Significanlty different from normal diet; * p<0.05, ** p<0.01
body weight 
(g)
food intake 
(g/day)
normal diet 448.9 ± 18.2 21.2 ± 1.4
HCD
without CP 518.2 ± 29.5** 22.4 ± 1.9*
with 0.5% CP 526.5 ± 54.8* 22.2 ± 1.4*
with 1.0% CP 517.6 ± 36.1** 22.8 ± 1.5*
Fig. 1. Changes in levels of plasma total cholesterol in rats fed
on the experimental diet. Values are presented as the
mean and standard deviation. Open circle; normal diet,
closed circle; high cholesterol diet, open square; 0.5%
CP-containing HCD diet, open triangle; 0.5% CP-
containing HCD diet. Significantly different from the
Normal Diet, ** p<0.01. Significantly different from the
HCD without CP, ##p<0.01.
Table 2. Plasma Lipid Concentration of Rats Fed the Experimental Diet
Values were mean and standard deviation. Significanlty different from normal diet, ** p<0.01
free cholesterol 
(mg/dl)
cholesterol ester 
(mg/dl)
tryglyceride 
(mg/dl)
phospholipid 
(mg/dl)
free fatty acid 
(mEq/l)
normal diet 10.9 ± 2.3 56.8 ± 5.4 75.7 ± 22.2 127.0 ± 15.3 0.71 ± 0.09
HCD
without CP 19.7 ± 11.2** 61.5 ± 12.6 78.7 ± 31.3 114.4 ± 10.6 0.77 ± 0.10
with 0.5% CP 17.2 ± 7.6** 64.1 ± 16.3 81.3 ± 22.3 118.6 ± 21.5 0.74 ± 0.10
with 1.0% CP 24.8 ± 12.5** 45.5 ± 19.5 71.7 ± 15.3 122.9 ± 24.0 0.78 ± 0.13N. Osakabe et al.
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polymerization. To elucidate the interaction of cholesterol
and procyanidins, a more detailed study is necessary.
Buijsse et al. analyzed the relationship between habitual
cocoa intake and cardiovascular diseases in 470 elderly men
participating in the Zutphen Elderly Study. They reported
that the adjusted relative risk of cardiovascular mortality for
men in the highest tertile of cocoa intake compared with
the lowest tertile was 0.5, and concluded that there was an
inverse relationship between cocoa intake and 15-year
cardiovascular mortality. Cocoa is a rich source of bioactive
compounds such as dietary fiber and magnesium as well as
procyanidins that have potential benefit for reducing the
risk of coronary artery disease. We have previously reported
that the contribution to prevention of cardiovascular disease
seems to be higher for procyanidins than for other compo-
nents. Kurosawa and Kusanagi-hypercholesterolemic rabbits
(a spontaneous familial hypercholesterolemic model) fed on
a diet containing 1.0% cocoa procyanidins fraction for 6
months showed significant reduction in atherosclerotic
lesion formation, and this reduction was similar to that in
other rabbits fed on a diet containing an equivalent amount
of cocoa procyanidins [23, 24].
Moreover, a recent intervention trial revealed that
supplementation with cocoa improves several risk factors
for coronary heart disease, such as blood pressure, insulin
sensitivity, vascular endothelial function, and the suscepti-
Table 3. Weight, Levels of Cholesterol and Fat in the Liver of Rats Fed the Experimental Diet
Values were mean and standard deviation.
Significanlty different from normal diet; * p<0.05, ** p<0.01
Significanlty different from HCD without CP; ## p<0.01
weight 
(g)
cholesterol 
(mg/liver)
triglyceride 
(g/liver)
normal diet 11.7 ± 1.0 9.2 ± 1.9 0.63 ± 0.10
HCD
without CP 26.8 ± 3.9** 404.7 ± 73.7** 7.69 ± 1.86**
with 0.5% CP 26.6 ± 2.6** 304.9 ± 49.7** 6.18 ± 0.86**
with 1.0% CP 24.9 ± 4.0** 285.1 ± 86.3**## 5.89 ± 1.84**##
Fig. 2. Excretion of neutral sterol (A) and triglyceride (B) in feces of rats fed on the experimental diet. Values are presented as the
mean and standard deviation. Significantly different from the Normal Diet (ND), ** p<0.01. Significantly different from the
HCD without CP, ## p<0.01.
Fig. 3. Effects of procyanidins on the solubility of cholesterol in
micelles. Values are presented as the means of three in-
dependent tests. Closed circle; CP, cross; monomer, open
square; dimer, closed square; trimer, open triangle; tet-
ramer.Cacao Procyanidins Reduce Rat Plasma Cholesterol
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bility of LDL to oxidation. In addition, we reported that
cocoa ingestion improves plasma lipid levels in our latest
intervention trial. Daily ingestion of two cups of cocoa for
12 weeks significantly decreased LDL in volunteer partici-
pants with total cholesterol level more than 200 mg/dl [25].
These data suggested that the improvement in plasma lipid
values is partially due to the ability of cocoa or its
procyanidin fractions to inhibit intestinal absorption of
cholesterol. Among the wide range of actions by CP on
risk factors for coronary heart disease, the inhibition of
cholesterol or bile acid absorption is one of the most impor-
tant.
Abbreviations
CP, cacao procyanidins; HCD, high cholesterol diet;
LDL, low-density lipoprotein; AIN, American Institute of
Nutrition.
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